Original title: A senescent-immune reserve niche model for incomplete lobular involution in the aging breast
Jaida C. Lue, Darren J. Baker, Amy C. Degnim, Stacey J. Winham +2 · May 2026
Breast cancer risk increases with age and peaks during menopause, but scientists do not fully understand why some milk-producing structures, called lobulessmall grape-like clusters in the breast that make milk., fail to shrink away. When these lobules remain, breast cancer risk rises. Rather than seeing this as a simple, passive breakdown of normal tissue shrinkage, the authors propose an active reserve nichea protected local environment that keeps certain cells alive and ready for future use.. They suggest that menopause acts as a biological fork in the road. If the immune system clears out senescent cellscells that have stopped dividing but don't die, and instead send signals that affect nearby tissue.—aging cells that have stopped dividing—lobules shrink completely. If immune surveillancethe immune system's routine job of finding and removing damaged or abnormal cells. fails, lingering senescent cells send inflammatory signals, alter macrophages, and dodge the immune system. This locks in a self-sustaining environment that keeps lobules active, highlighting the menopausal window for future risk tracking and prevention.
Imagine a vegetable patch at the end of autumn. Most plants die back on schedule, but a few stubborn stalks stay green, and any gardener knows those stragglers are trouble; the usual assumption is that they just missed the signal to die. A closer look shows the soil around them is kept warm and watered, and the crew that clears dead plants never arrives. In this paper, the leftover breast tissue is those stalks, and the warm soil is a self-sustaining neighborhood of aging cells and immune cells that keeps it alive.
Breast cancer risk rises with age and peaks around menopause, and leftover breast lobules are a strong predictor of later cancer. This paper reframes that leftover tissue as an active, changeable environment rather than passive debris. If that's right, the perimenopausal years become a real window for checking who is at risk and possibly intervening before cancer forms.
The abstract doesn't state limitations explicitly; it offers a framework synthesized from several fields rather than direct experimental proof. It does not specify how to measure the niche in patients, which biomarkers would work, or whether intervening in the perimenopausal window actually lowers breast cancer risk.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
A senescent-immune reserve niche model for incomplete lobular involution in the aging breast — Jaida C. Lue, Darren J. Baker, Amy C. Degnim et al.
Abstract licence: CC0
Explanation generated by Synthesis from the abstract — it is not the original paper. This is a preprint, so it hasn't necessarily been peer reviewed.